Amid growing concern over access to Covid-19 medical products, Moderna (MRNA) has decided not to enforce its patent rights related to its experimental vaccine and will also license its intellectual property to any Covid-19 vaccines to others after the pandemic has ended.
The decision means other companies or governments should not have concerns that the biotech would seek to prevent other Covid-19 vaccines from being developed based on its technology. “We feel a special obligation under the current circumstances to use our resources to bring this pandemic to an end as quickly as possible,” the company said in a brief statement (here are the patents).
About the Author Reprints
May one observe we should hope that – ““Every manufacturer of a vaccine, drug or diagnostic should follow suit … “
KEI has more commentary the Moderna statement here: https://www.keionline.org/34112